Efficacy of certain quinolines as pharmacological antagonists in botulinum neurotoxin poisoning

Toxicon

Volumn 35, Issue 3, 1997, Pages 433-445

  Deshpande, Sharad S ^a   Sheridan, Robert E ^a   Adler, Michael ^a  

^a Neurotoxicology Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 (4 AMINO 1 METHYLBUTYLAMINO) 5 HEXYLOXY 6 METHOXY 4 METHYLQUINOLINE; AMODIAQUINE; ANTIMALARIAL AGENT; BOTULINUM TOXIN; CHLOROQUINE; MEPACRINE; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; PRIMAQUINE; PYRIMETHAMINE; QUINIDINE; QUININE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM; DOSE RESPONSE; IN VITRO STUDY; MALE; MOUSE; MUSCLE CONTRACTURE; NEUROMUSCULAR BLOCKING; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; BOTULINUM TOXIN TYPE A; DRUG EVALUATION, PRECLINICAL; MALE; MICE; MUSCLE SPASTICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; CINCHONA PUBESCENS;

EID: 0031106637     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(96)00147-X     Document Type: Article

References (28)

1. Bakry, N., Kamata, Y. and Simpson, L. L. (1991) Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. J. Pharmac. exp. Ther. 258, 830-836.
2. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Sudhof, T., Jahn, R. and Niemann, H. (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. biol. Chem. 269, 1617-1620.
3. 125I]-labelled botulinum neurotoxin with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerve by acceptor-mediated endocytosis. J. Cell Biol. 103, 535-544.
4. Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Sudhof, T. C., Niemann, H. and Jahn, R. (1993a) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature, Lond. 365, 160-163.
5. Blasi, J., Chapman, E. R., Yamasaki, S., Binz, T., Niemann, H. and Jahn, R. (1993b) Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. Eur. molec. Biol. Org. J. 12, 4821-4828.
6. Deshpande, S. S., Sheridan, R. E. and Adler, M. (1995) A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon 33, 551-557.
7. Fujii, N., Kimura, K., Yokosawa, N., Tsuzuki, K. and Oguma, K. (1992) A zinc-protease specific domain in botulinum and tetanus neurotoxins. Toxicon 30, 1486-1488.
8. Kurazono, H., Mochida, S., Binz, T., Eisel, U., Quanz, M., Grebenstein, O., Wernars, K., Poulain, B., Tauc, L. and Niemann, H. (1992) Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A. J. biol. Chem, 267, 14721-14729.
9. MacDonald, R. D. and Engel, A. G. (1970) Experimental chloroquine myopathy. J. Neurosurg. exp. Neurol. 29, 479-499.
10. Marino, M. T., Peggins, J. O., Brown, L. D., Urquhart, M. R. and Brewer, T. G. (1994) Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511). Drug Metab. Disp. 22, 358-366.
11. Okwuasaba, F. K., Otuba, J. A. M. and Udoh, F. V. (1990) Mode of inhibitory action of acute and chronic chloroquine administration on the electrically stimulated mouse diaphragm in vitro. Br. J. Pharmac. 101, 133-139.
12. Schiavo, G., Benfenati, F., Poulain, B., Rossetto, O., Polverino de Laureto, P., DasGupta, B. R. and Montecucco, C. (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature, Lond. 359, 832-835.
13. Schiavo, G., Shone, C. C., Rossetto, O., Alexander, F. C. G. and Montecucco, C. (1993) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. biol. Chem. 268, 11516-11519.
14. Schiavo, G., Malizio, C., Trimble, W. S., Polverino de Laureto, P., Milan, G., Sugiyama, H., Johnson, E. A. and Montecucco, C. (1994) Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single A1a-A1a peptide bond. J. biol. Chem. 269, 20213-20216.
15. Schmid, A., Benz, R., Just, I. and Aktories, K. (1994) Interaction of Clostridium botulinum C toxin with lipid bilayer membranes: formation of cation-selective channels and inhibition of channel function by chloroquine. J. biol. Chem. 269, 16706-16711.
16. Sheridan, R. E. (1996) Protonophore antagonism of botulinum neurotoxin in mouse muscle. Toxicon 34, 849-855.
17. Sheridan, R. E. and Deshpande, S. S. (1995) Interactions between heavy metal chelators and botulinum neurotoxins at the mouse neuromuscular junction. Toxicon 33, 539-549.
18. Sieb, J. P., Milone, M. and Engel, A. G. (1996) Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Res. 712, 179-189.
19. Simpson, L. L. (1980) Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J. Pharmac. exp. Ther. 212, 16-21.
20. Simpson, L. L. (1982) The interaction between aminoquinolines and presynaptically acting neurotoxins. J. Pharmac. exp. Ther. 222, 43-48.
21. Simpson, L. L. (1983) Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. J. Pharmac. exp. Ther. 225, 546-552.
22. Simpson, L. L. (1989) Peripheral actions of the botulinum toxins. In: Botulinum Neurotoxin and Tetanus Toxin, pp. 153-178 (Simpson, L. L., Ed.). New York: Academic Press.
23. Simpson, L. L., Coffield, J. A. and Bakry, N. (1993) Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin. J. Pharmac. exp. Ther. 267, 720-727.
24. 2 neurotoxins. J. Pharmac. exp. Ther. 269, 256-262.
25. Tsai, M.-C., Oliveira, A. C., Albuquerque, E. X., Eldefrawi, M. E. and Eldefrawi, A. T. (1979) Mode of action of quinacrine on the acetylcholine receptor ionic channel complex. Molec. Pharmac. 16, 382-392.
26. Wannemacher, R. W., Dinterman, R. E., Deshpande, S. S. and Adler, M. (1995) Efficacy of zinc chelator, N′,N,N′,N′-tetrakis(2-pyridyl-methyl)ethylene-diamine (TPEN), against botulinum type-A or B neurotoxin in mice. Toxicon 33, 271.
27. Webster, L. T., Jr (1990) Drugs used in the chemotherapy of protozoal infections. In: The Pharmacological Basis of Therapeutics, 8th Edn, p. 982 (Goodman Gilman, A., Rall, T. W., Nies, A. S. and Taylor, P., Eds). New York: Pergamon Press.
28. Yamasaki, S., Hu, Y., Binz, T., Kalkuhl, A., Kurazono, H., Tamura, T., Jahn, R., Kandel, E. and Niemann, H. (1994) Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc. natn. Acad. Sci. U.S.A. 91, 4688-4692.